We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
-20.97%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$184M
AUM Growth
-$292M
Cap. Flow
-$238M
Cap. Flow %
-129.38%
Top 10 Hldgs %
72.16%
Holding
80
New
10
Increased
15
Reduced
25
Closed
17

Sector Composition

Rank Sector Weight
1 Miscellaneous 71.2%
2 Healthcare 26.49%
3 Real Estate 1.23%
4 Materials 0.28%
5 Financials 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMR
26
DELISTED
BIOMED REALTY TRUST INC
BMR
$1.29M 0.7%
64,584
VDE icon
27
Vanguard Energy ETF
VDE
$10.7B
$1.17M 0.63%
13,769
+10,839
+370% +$1.03M
ARE icon
28
Alexandria Real Estate Equities
ARE
$8.87B
$976K 0.53%
11,529
+5,020
+77% +$451K
SPY icon
29
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$942K 0.51%
4,916
+3,132
+176% +$635K
VV icon
30
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
$887K 0.48%
10,079
+7
+0.1% +$653
EWJ icon
31
iShares MSCI Japan ETF
EWJ
$22.7B
$820K 0.45%
17,934
-155,522
-90% -$7.67M
NBIX icon
32
Neurocrine Biosciences
NBIX
$15.7B
$597K 0.32%
15,000
VWO icon
33
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$564K 0.31%
17,055
-254,250
-94% -$9.23M
DXJ icon
34
WisdomTree Japan Hedged Equity Fund
DXJ
$7.34B
$563K 0.31%
11,570
-64,867
-85% -$3.51M
VEU icon
35
Vanguard FTSE All-World ex-US ETF
VEU
$70.4B
$531K 0.29%
12,452
-102,503
-89% -$4.73M
KND
36
DELISTED
Kindred Healthcare
KND
$521K 0.28%
33,078
+6,610
+25% +$134K
MON
37
DELISTED
Monsanto Co
MON
$520K 0.28%
6,098
MBFI
38
DELISTED
MB Financial Corp
MBFI
$513K 0.28%
15,705
AAXJ icon
39
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.88B
$512K 0.28%
9,697
-25,535
-72% -$1.44M
DSI icon
40
iShares MSCI KLD 400 Social ETF
DSI
$5.53B
$466K 0.25%
13,138
RLY icon
41
State Street Multi-Asset Real Return ETF
RLY
$1.35B
$463K 0.25%
20,425
-33,538
-62% -$808K
DBEF icon
42
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.38B
$452K 0.25%
17,329
-660,039
-97% -$18.5M
MLPX icon
43
Global X MLP & Energy Infrastructure ETF
MLPX
$3.63B
$441K 0.24%
10,834
-12,775
-54% -$615K
CMBS icon
44
iShares CMBS ETF
CMBS
$472M
$410K 0.22%
7,910
-22,509
-74% -$1.16M
ZVO
45
DELISTED
Zovio Inc. Common Stock
ZVO
$378K 0.21%
49,650
-67,074
-57% -$573K
EPP icon
46
iShares MSCI Pacific ex Japan ETF
EPP
$2.32B
$348K 0.19%
9,502
-129,911
-93% -$5.21M
TSLA icon
47
Tesla
TSLA
$1.38T
$335K 0.18%
20,250
+300
+2% +$5.1K
EBND icon
48
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.29B
$332K 0.18%
13,503
-44,638
-77% -$1.14M
SQNM
49
DELISTED
SEQUENOM INC NEW
SQNM
$309K 0.17%
176,477
-100,000
-36% -$245K
EWC icon
50
iShares MSCI Canada ETF
EWC
$6.85B
$296K 0.16%
12,889
-154,077
-92% -$3.79M

Similar funds

Callan Capital's Q3 2015 Portfolio in Review

As of Q3 2015, Callan Capital held 80 positions worth $184M, down 61% from $477M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Callan Capital withdrew a net $238M in Q3 2015, closing 17 positions and reducing 25 holdings. Its most notable exit was RECEPTOS INC COM STK (DE), an estimated $160M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 71% of assets, down from 97% a quarter earlier, followed by Healthcare and Real Estate.

Against the trend, Callan Capital opened a new position in ImmunityBio worth $41.6M.

  • Callan Capital's largest Q3 2015 buy was ImmunityBio: 3,632,461 shares worth $41.6M.
  • Callan Capital added most to Vanguard Energy ETF in Q3 2015, an estimated $1.03M increase.
  • Callan Capital's biggest Q3 2015 reduction was Vanguard FTSE Europe ETF, cutting an estimated $25.8M.
  • Callan Capital fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $160M.
  • Callan Capital's ten largest holdings make up 72% of its $184M portfolio in Q3 2015.
  • Callan Capital opened 10 new positions and closed 17 in Q3 2015.
  • Callan Capital's portfolio value fell 61% quarter-over-quarter to $184M.

Based on Callan Capital's 13F filing for Q3 2015, filed 10 Nov 2015.